CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.52
+3.17%Margins
Gross margin
-319.3%
EBITDA margin
-3092.5%
EBIT margin
-3329.0%
Net margin
-3376.3%
FCF margin
-2982.5%
-268.8%
Return on equity
-143.0%
Return on assets
-171.9%
Return on invested capital
0.04x
Asset turnover
-$11.6M
Cash from operations
$0.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026